Hisamitsu Pharmaceutical Co., Inc. (4530.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Hisamitsu Pharmaceutical Co., Inc.
Address
408, Tashiro Daikan-machi
Tosu, 841-0017
Japan
Phone
81 3 5293 1720
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2759
First IPO Date
January 01, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Kazuhide Nakatomi | President, Chief Executive Officer & Representative Director | 0 | 1972 |
| Mitsutoshi Tsuruta | Senior Executive Officer & Head of Sales & Marketing Division of RX | 0 | N/A |
| Kyu Saito | MD, Executive Officer & Director | 0 | 1963 |
| Shinichi Murayama | Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | 0 | 1967 |
| Masaya Okuno | Senior Executive Officer & Head of Sales & Marketing Division of OTC | 0 | N/A |
| Kosuke Sugiyama | Senior MD & Exec. Officer of Human Resources & R&D and Corporate Strategy Planning | 0 | 1952 |
| Naruhito Higo | Managing Exec. Officer & Head of Global Tech. Dev., MN Business Promo. & QA & Pharmacovigilance | 0 | N/A |
| Tetsuo Akiyama | Senior Managing Executive Officer, Head of Business Operations & Head of BU | 0 | N/A |
| Nobuo Tsutsumi | Exe. Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director | 0 | 1964 |
| Hidenao Minami | Executive Officer of Public Relations | 0 | N/A |
Description
Hisamitsu Pharmaceutical Co., Inc. is a Japanese enterprise specializing in the development, manufacturing, and distribution of a wide array of healthcare solutions. Its extensive product catalog includes pharmaceuticals, medical devices, quasi-drugs, and cosmetics, catering to markets in Japan, the United States, and Asia. The company is particularly recognized for its comprehensive range of external pain relief medications, featuring popular brands such as SALONPAS, NOBINOBI, SALONSIP, AIR, and FEITAS. Additionally, Hisamitsu offers various transdermal patches for pain and inflammation, including MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Beyond pain management, its portfolio addresses other conditions with products like BUTENALOCK for athlete's foot and ALLEGRA FX for allergy and sinus symptoms. Specialized therapeutic patches for female hormone regulation, asthma, overactive bladders, and the HFT-290 patch for cancer pain further highlight its diverse pharmaceutical offerings. Founded in Tosu, Japan, in 1847, Hisamitsu Pharmaceutical boasts a rich history in the industry.
